Hemodynamically massive PE | Anatomically massive PE | |||||
---|---|---|---|---|---|---|
UK 12 h (n = 20) | UK 2 h (n = 20) | p | UK 12 h (n = 50) | UK 2 h (n = 39) | p | |
Efficacy | ||||||
Pulmonary artery obstruction score by CTPA* | ||||||
Baseline | 16.1 ± 7.7 | 17.3 ± 10.5 | 0.670 | 13.7 ± 7.2 | 14.7 ± 7.6 | 0.523 |
24 -hour | 13.1 ± 7.7 | 13.5 ± 11.7 | 0.899 | 10.5 ± 6.9 | 10.9 ± 8.1 | 0.783 |
14- day | 6.9 ± 7.3 | 5.2 ± 9.8 | 0.527 | 4.5 ± 5.2 | 3.7 ± 4.6 | 0.452 |
Adverse events | ||||||
Death | 0 (0) | 2 (10.0) | 0.487 | 1(2)**** | 0(0) | 1.000 |
Due to PE | 0(0) | 1 (5.0)** | 0 (0) | 0(0) | ||
Due to other reason | 0(0) | 1 (5.0)*** | 0 (0) | 0(0) | ||
Due to Bleeding | 0 (0) | 0(0) | 0 (0) | 0(0) | ||
Recurrent PE | 0 (0) | 0(0) | 1(2) | 0(0) | ||
Bleeding complications | 3(15) | 3(15) | 1.000 | 7(14) | 5(13) | 1.000 |
Major bleeding | 1 (5.0) | 3 (15.0) | 0.605 | 3 (6) | 3 (7.7) | 1.000 |
Fatal bleeding | 0 (0) | 0(0) | 0(0) | 0(0) | ||
Other | 1 (5.0) | 3 (15.0) | 3(6) | 3 (7.7) | ||
Minor bleeding | 2(10.0) | 0(0.0) | 0.487 | 4(8) | 2(5.1) | 0.692 |